Does Dr. SIXTO GIUSTI have financial conflicts of interest?

Dr. SIXTO GIUSTI (MD) has received a total of $22,685 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $22,685 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SIXTO GIUSTI?

According to CMS Open Payments data, Dr. SIXTO GIUSTI received funding from MALLINCKRODT HOSPITAL PRODUCTS ($22,537), UNITED THERAPEUTICS CORPORATION ($133), and VELOXIS PHARMACEUTICALS ($15).

Does Dr. SIXTO GIUSTI receive research grants or speaking fees?

Dr. SIXTO GIUSTI has received $22,685 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SIXTO GIUSTI

MDReal-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: AURORA, CO 80045

NPI Number: 1134413792

LIFETIME INDUSTRY VALUE

$22,685

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. GIUSTI is a verified Internal Medicine, Nephrology practitioner based in AURORA, CO.

Between 2021 and 2025, Dr. GIUSTI had an overall industry promotional and research financial footprint of $22,685 as recorded in the federal CMS Open Payments database.

$22,685 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. GIUSTI's primary funding source is MALLINCKRODT HOSPITAL PRODUCTS, which accounts for $22,537 (representing 99.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

MALLINCKRODT HOSPITAL PRODUCTS

Rank 1

$22,537

99.3%

UNITED THERAPEUTICS CORPORATION

Rank 2

$133

0.6%

VELOXIS PHARMACEUTICALS

Rank 3

$15

0.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.